Your browser doesn't support javascript.
loading
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy.
Beyranvand Nejad, Elham; Labrie, Camilla; Abdulrahman, Ziena; van Elsas, Marit J; Rademaker, Eva; Kleinovink, Jan Willem; van der Sluis, Tetje C; van Duikeren, Suzanne; Teunisse, Amina F A S; Jochemsen, Aart G; Oosting, Jan; de Miranda, Noel F C C; Van Hall, Thorbald; Arens, Ramon; van der Burg, Sjoerd H.
Afiliação
  • Beyranvand Nejad E; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Labrie C; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Abdulrahman Z; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Elsas MJ; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Rademaker E; Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Kleinovink JW; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • van der Sluis TC; Immunohematology and Bloodtransfusion, Leiden Universitair Medisch Centrum, Leiden, The Netherlands.
  • van Duikeren S; Immunohematology and Bloodtransfusion, Leiden Universitair Medisch Centrum, Leiden, The Netherlands.
  • Teunisse AFAS; Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • Jochemsen AG; Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • Oosting J; Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • de Miranda NFCC; Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Van Hall T; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Arens R; Immunohematology and Bloodtransfusion, Leiden Universitair Medisch Centrum, Leiden, The Netherlands.
  • van der Burg SH; Oncode institute, Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands shvdburg@lumc.nl.
J Immunother Cancer ; 8(2)2020 09.
Article em En | MEDLINE | ID: mdl-32873723
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Células Mieloides / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Células Mieloides / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article